SpaceX IPO launches today. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSpirax-Sarco Regulatory News (SPX)

Share Price Information for Spirax-Sarco (SPX)

Share Price is delayed by 15 minutes
Get Live Data
6,760.00    65.00 (0.97%)
Bid:
6,755.00
Ask:
6,760.00
Spread: 5.00 (0.074%)
Market Cap: £4.99b
SPX Live PriceLast checked at - London Stock Exchange

Intraday Spirax-Sarco Share Chart

IFRS Statement

12 Jul 2005 09:30

Spirax-Sarco Engineering PLC12 July 2005 Spirax-Sarco Engineering plc Charlton House Cheltenham Glos. GL53 8ER News Release Telephone: 01242 521361 Fax: 01242 581470 www.SpiraxSarcoEngineering.com 12th July 2005 Restatement of primary financial information for 2004 under International Financial Reporting Standards Spirax-Sarco Engineering plc and its subsidiaries (the Group) has for theaccounting periods up to 31st December 2004 prepared its consolidated financialstatements under UK Generally Accepted Accounting Principles (UK GAAP). From1st January 2005, the Group is required by European Directives to report itsconsolidated financial statements under International Financial ReportingStandards (IFRS). As part of this transition, the Group is presenting a restatement of its 2004results under IFRS. This will form the comparative to the 2005 Interim Reportand the 2005 Annual Report. A summary of the effect of the restatement follows:- Year ended 31st December 2004 Change in Change in UK Minorities Pensions (IAS 19) Other IFRS GAAP (IAS 27) £m Changes IFRS £m £m £m £m Revenue 325.8 (9.8) nil nil 316.0Operating profit 51.1 (2.5) (1.0) 0.4 48.0Profit before tax 50.8 (1.8) (0.7) 0.4 48.7Basic EPS (p) 43.4p nil (0.9p) 0.6p 43.1pNet assets attributable toshareholders 178.0 nil (27.0) 13.0 164.0 Six months ended 30th June 2004 Change in Change in UK Minorities Pensions (IAS 19) Other IFRS GAAP (IAS 27) £m Changes IFRS £m £m £m £m Revenue 157.7 (4.8) nil nil 152.9Operating profit 23.4 (1.1) (0.4) 0.2 22.1Profit before tax 23.1 (0.8) (0.3) 0.2 22.2Basic EPS (p) 19.6p nil (0.4p) 0.5p 19.7pNet assets attributable toshareholders 168.5 nil (30.7) 5.7 143.5 The principal changes from the transition to IFRS are: Change in minorities • Reassessing control in minority interests resulting in a change in the treatment of the Group's investments in India and Mexico on consolidation from subsidiary companies to associate companies. Although there is a reduction in 2004 sales of £9.8 million and in pre-tax profit of £1.8 million, there is no change in EPS or net assets attributable to shareholders. Change in pensions • Recognising the deficit on defined benefit pension schemes on the balance sheet and the higher income statement charge for pensions under IAS 19. For the 2004 year £27.0 million of additional balance sheet net liabilities have been recognised and the income statement charge (before tax) increases by £0.7 million. Other IFRS changes • Recording the cost of share options awarded to employees on a fair value basis. The 2004 income statement charge (before tax) increases by £0.4 million. • Ceasing goodwill amortisation (subject to annual impairment testing). The 2004 income statement reflects the reversal of the £0.7 million charge under UK GAAP. • Not accruing a liability for dividends that have not been declared or approved at the balance sheet date. Shareholders funds increase by £11.4 million at 31st December 2004. • Capitalisation of the development element of R&D expenditure under certain circumstances. Net intangible assets increase by £2.5 million (before tax effects) at 31st December 2004. Changes to the income statement are immaterial. • Providing deferred tax on property revaluations. This results in the creation of a £1.8 million deferred tax liability at 31st December 2004. The effect of the adoption of IFRS in respect of the Group's 2004 financialstatements is set out in detail in a report that can be downloaded from thecompany's website at www.SpiraxSarcoEngineering.com. Alternatively copies canbe obtained from the Company Secretary at Charlton House, Cheltenham, Glos. GL538ER. The Group intends to announce the interim results for the six months ended 30thJune 2005 on Tuesday 6th September 2005. Enquiries: Marcus Steel - Chief ExecutiveDavid Meredith - Director Finance Tel: 01242 521361Fax: 01242 581470 www.SpiraxSarcoEngineering.com This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
1st Mar 20227:30 amRNSChange of Director Details
31st Jan 20227:00 amRNSCompletion of the acquisition of Cotopaxi
24th Jan 20227:00 amRNSAcquisition to accelerate digital strategy
17th Nov 20217:00 amRNSTrading Update
15th Nov 20211:54 pmRNSDirector/PDMR Shareholding
11th Aug 20214:46 pmRNSCorrection to Dividend Record Date in News Release
11th Aug 20217:00 amRNS2021 Half Year Results
3rd Aug 20217:00 amRNSBoard Changes
22nd Jun 20217:00 amRNSDirector/PDMR Shareholding
17th Jun 20217:00 amRNSNew Sustainability Targets Launched
4th Jun 20218:12 amRNSDirector/PDMR Shareholding
19th May 20217:00 amRNSNews Release - Investor Seminar
12th May 20214:53 pmRNSResult of AGM
12th May 20217:00 amRNSAGM TRADING UPDATE
10th May 20219:16 amRNSDirector/PDMR Shareholding
12th Apr 202111:44 amRNSDirector/PDMR Shareholding
26th Mar 20218:12 amRNSDirector/PDMR Shareholding
10th Mar 20217:00 amRNS2020 Preliminary Results
9th Mar 20218:30 amRNSBoard Appointment
7th Jan 20214:05 pmRNSDirector/PDMR Shareholding
14th Dec 202010:00 amRNSDirector/PDMR Shareholding
18th Nov 20207:00 amRNSTrading Update
9th Nov 20209:00 amRNSBoard Appointments
21st Oct 20209:21 amRNSChange of Director Details
12th Oct 20205:08 pmRNSDirector/PDMR Shareholding
12th Oct 202010:00 amRNSDirectorate Change
14th Sep 20208:00 amRNSChief Financial Officer
18th Aug 20204:19 pmRNSDirector/PDMR Shareholding
12th Aug 20207:00 amRNS2020 Half Year Results
6th Aug 20208:00 amRNSAdditional Listing
28th Jul 202012:24 pmRNSSection 430(2b) Companies Act - Nimesh Patel
23rd Jul 20207:30 amRNSChange of Director Details
22nd Jun 20203:39 pmRNSChange of Director Details
22nd Jun 20202:45 pmRNSDirector/PDMR Shareholding
20th May 20209:00 amRNSChange of Director Details
13th May 20204:32 pmRNSResult of AGM
13th May 20207:00 amRNSAGM Statement - Trading Update
28th Apr 202011:30 amRNSDisclosure of Rights attached to Equity Shares
24th Apr 20208:59 amRNSAGM Alternative Arrangements
8th Apr 202010:33 amRNSSection 430(2B) Companies Act 2006 Statement
3rd Apr 202011:14 amRNSDirector/PDMR Shareholding
2nd Apr 20208:00 amRNSSpirax Sarco appoints next Chief Financial Officer
30th Mar 20208:30 amRNSChange of Director Details
13th Mar 20209:48 amRNSDirector/PDMR Shareholding
12th Mar 202012:00 pmRNSDirector/PDMR Shareholding
11th Mar 20207:05 amRNSBoard Change
11th Mar 20207:00 amRNS2019 Preliminary Results
7th Feb 20205:35 pmRNSDirector Declaration
13th Nov 20197:00 amRNSTrading Update
10th Sep 20193:30 pmRNSChange of Director Details

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.